Ten years experience in the management of borderline ovarian tumors at Tom Baker Cancer Centre

Archives of Gynecology and Obstetrics

Volumn 284, Issue 3, 2011, Pages 731-735

  Anfinan, Nisrin ^a   Sait, Khalid ^b   Ghatage, Prafull ^a   Nation, Jill ^a   Chu, Pam ^a  

^a TOM BAKER CANCER CENTRE   (Canada)

^b KING ABDUL AZIZ UNIVERSITY HOSPITAL   (Saudi Arabia)

Author keywords

Borderline ovarian tumor; Recurrence; Survival

Indexed keywords

CARBOPLATIN; PACLITAXEL;

ABDOMINAL HYSTERECTOMY; ADOLESCENT; ADULT; AGED; ARTICLE; BORDELINE OVARIAN TUMOR; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; FEMALE; HUMAN; LAPAROTOMY; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; OVARY TUMOR; OVERALL SURVIVAL; RADICAL HYSTERECTOMY; RETROSPECTIVE STUDY; RISK ASSESSMENT; SALPINGOOOPHORECTOMY; ADJUVANT CHEMOTHERAPY; CANCER INVASION; CONSERVATIVE TREATMENT; DISEASE FREE SURVIVAL; HYSTERECTOMY; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; METASTASIS; METHODOLOGY; MIDDLE AGED; OVARIECTOMY; PATHOLOGY; PERITONEUM TUMOR; PROPORTIONAL HAZARDS MODEL; REPRODUCTIVE PROCEDURES; SALPINGECTOMY; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; FERTILITY PRESERVATION; HUMANS; HYSTERECTOMY; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; ORGAN SPARING TREATMENTS; OVARIAN NEOPLASMS; OVARIECTOMY; PERITONEAL NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SALPINGECTOMY; YOUNG ADULT;

EID: 84856015471     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-010-1713-9     Document Type: Article

References (21)

1. Gotlieb WH, Flikker S, Davidson B, Korach Y, Kopolovic J, Ben-Baruch G (1998) Borderline tumors of the ovary: fertility treatment, conservative management, and pregnancy outcome. Cancer 82:141-146 (Pubitemid 28070490)
2. Kennedy AW, Hart RH (1996) Ovarian papillary serous tumors of low malignant potential (serous borderline tumors): a long term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma. Cancer 78:278-286 (Pubitemid 26234571)
3. Gershenson DM (2002) Clinical management potential tumours of low malignancy. Best Pract Res Clin Obstet Gynaecol 16:513-527 (Pubitemid 41123405)
4. Fauvet R, Boccara J, Dufournet C, David-Montefiore E, Poncelet C, Darai E (2004) Restaging surgery for women with borderline ovarian tumors: results of a French multicenter study. Cancer 100:1145-1151 (Pubitemid 38325941)
5. Boran N, Cil AP, Tulunay G, Ozturkoglu E, Koc S, Bulbul D, Kose MF (2005) Fertility and recurrence results of conservative surgery for borderline ovarian tumors. Gynecol Oncol 97:845-851 (Pubitemid 40824656)
6. Morice P, Camette S, El Hassan J, Pautier P, Duvillard P, Castaigne D (2001) Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors. Fertil Steril 75:92-96 (Pubitemid 32041230)
7. Ayhan A, Celik H, Taskiran C, Bozdag G, Aksu T (2003) Oncologic and reproductive outcome after fertility-saving surgery in ovarian cancer. Eur J Gynaecol Oncol 24:223-232 (Pubitemid 36644604)
8. Scully RE (1982) Common epithelial tumors of borderline malignancy (carcinomas of low malignant potential). Bull Cancer 69:228-238 (Pubitemid 12052997)
9. International Federation of Gynecology and Obstetrics (1987) Changes in definitions of clinical staging for carcinoma of the cervix and ovary. Am J Obstet Gynecol 156:263-264
10. Trope C, Kaern J (1998) Management of borderline tumors of the ovary: state of the art. Semin Oncol 25:372-380 (Pubitemid 28272612)
11. Gershenson DM, Silva EG, Tortolero-Luna G, Levenback C, Morris M, Tornos C (1998) Serous borderline tumor of the ovary with noninvasive peritoneal implants. Cancer 83:2157-2163 (Pubitemid 28525397)
12. Gershenson DM, Silva EG, Levy L, Burke TW, Wolf JK, Tornos C (1998) Ovarian serous borderline tumors with invasive peritoneal implants. Cancer 82:1096-1103 (Pubitemid 28136523)
13. Leake JF, Currie JL, Rosenshein NB, Woodruff JD (1992) Longterm follow-up of serous ovarian tumors of low malignant potential. Gynecol Oncol 47:150-158 (Pubitemid 23001321)
14. Tazelaar HD, Bostwick DG, Ballon SC, Hendrickson MR, Kempson RL (1985) Conservative treatment of borderline ovarian tumors. Obstet Gynecol 66:417-422 (Pubitemid 15016587)
15. Casey AC, Bell DA, Lage JM, Fuller AF, Nikrui N, Rice LW (1993) Epithelial ovarian tumors of borderline malignancy: longterm follow-up. Gynecol Oncol 50:316-322 (Pubitemid 23299726)
16. Camatte S, Morice P, Thoury A, Fourchotte V, Pautier P, Lhomme C, Duvillard P, Castaigne D (2004) Impact of surgical staging in patients with macroscopic "stage I" ovarian borderline tumours: analysis of a continuous series of 101 cases. Eur J Cancer 40:1842-1849 (Pubitemid 39036758)
17. Winter WE 3rd, Kucera PR, Rodgers W, McBroom JW, Olsen C, Maxwell GL (2002) Surgical staging in patients with ovarian tumors of low malignant potential. Obstet Gynecol 100:671-676 (Pubitemid 35300021)
18. Trimble CL, Kosary C, Trimble EL (2002) Long-term survival and patterns of care in women with ovarian tumors of low malignant potential. Gynecol Oncol 86:34-37 (Pubitemid 34757048)
19. Bell DA, Scully RE (1990) Ovarian serous borderline tumors with stromal microinvasion: a report of 21 cases. Hum Pathol 21:397-403 (Pubitemid 20141024)
20. Buttin BM, Herzog TJ, Powell MA, Rader JS, Mutch DG (2002) Epithelial ovarian tumors of low malignant potential: the role of microinvasion. Obstet Gynecol 99(1):11-17 (Pubitemid 34075461)
21. Seidman JD, Kurman RJ (2000) Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum Pathol 31:539-557 (Pubitemid 30323979)